Causes of death and risk factors for mortality among HIV-infected patients receiving antiretroviral therapy in Korea

A retrospective study was conducted to determine the mortality, causes and risk factors for death among HIV-infected patients receiving antiretroviral therapy (ART) in Korea. The outcomes were determined by time periods, during the first year of ART and during 1-5 yr after ART initiation, respectively. Patients lost to follow-up were traced to ascertain survival status. Among 327 patients initiating ART during 1998-2006, 68 patients (20.8%) died during 5-yr follow-up periods. Mortality rate per 100 person-years was 8.69 (95% confidence interval, 5.68-12.73) during the first year of ART, which was higher than 4.13 (95% confidence interval, 2.98-5.59) during 1-5 yr after ART. Tuberculosis was the most common cause of death in both periods (30.8% within the first year of ART and 16.7% during 1-5 yr after ART). During the first year of ART, clinical category B and C at ART initiation, and underlying malignancy were significant risk factors for mortality. Between 1 and 5 yr after ART initiation, CD4 cell count ≤ 50 cells/µL at ART initiation, hepatitis B virus co-infection, and visit constancy ≤ 50% were significant risk factors for death. This suggests that different strategies to reduce mortality according to the time period after ART initiation are needed.

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:28

Enthalten in:

Journal of Korean medical science - 28(2013), 7 vom: 01. Juli, Seite 990-7

Sprache:

Englisch

Beteiligte Personen:

Lee, Sun Hee [VerfasserIn]
Kim, Kye-Hyung [VerfasserIn]
Lee, Seung Geun [VerfasserIn]
Cho, Heerim [VerfasserIn]
Chen, Dong Hwan [VerfasserIn]
Chung, Joo Seop [VerfasserIn]
Kwak, Ihm Soo [VerfasserIn]
Cho, Goon Jae [VerfasserIn]

Links:

Volltext

Themen:

Anti-Retroviral Agents
Antiretroviral Therapy
Cause of Death
HIV
Journal Article
Loss to Follow-up
Mortality
Research Support, Non-U.S. Gov't
Retention in Care
Risk Factors
Visit Constancy

Anmerkungen:

Date Completed 21.03.2014

Date Revised 11.03.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.3346/jkms.2013.28.7.990

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM229160921